Safe Accelerated Venetoclax Escalation in CLL
Clinical trial NCT04843904 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04843904
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2025-06-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.